Division of Orthopaedics and Traumatology (University Hospital Krems)

Medicine and Dentistry

1. 6 Diazo 5 Oxonorleucine 27%
2. Adipose-Derived Mesenchymal Stem Cell 54%
3. Adjuvant Radiotherapy 27%
4. Adolescence 54%
5. Aneurysmal Bone Cyst 27%
6. Anterior Cruciate Ligament Reconstruction 27%
7. Arthroplasty 19%
8. Arthroscopy 27%
9. Articular Surface 27%
10. Attitude 27%
11. Blood Product 54%
12. Body Mass Index 63%
13. Bone Marrow Biopsy 27%
14. Brachytherapy 81%
15. Chondrocyte 54%
16. Chondrosarcoma 13%
17. Clinical Finding 27%
18. Conservative Treatment 30%
19. Cross Sectional Study 37%
20. Cytotoxicity 27%
21. Day of Surgery 13%
22. Diagnosis 86%
23. Digitalization 27%
24. Diseases 14%
25. Drug Megadose 27%
26. Glucocorticoid 27%
27. Growth Period 27%
28. Hazard Ratio 20%
29. High Tibial Osteotomy 27%
30. Hip Arthroplasty 27%
31. Iliac Crest 18%
32. Implant 97%
33. In Vitro 27%
34. Infrapatellar Fat Pad 27%
35. Injury 30%
36. Internal Fixation 27%
37. Joint Function 27%
38. Knee 87%
39. Knee Arthroplasty 31%
40. Knee Arthroscopy 27%
41. Knee Injury and Osteoarthritis Outcome Score 24%
42. Knee Joint 31%
43. Knee Meniscus Rupture 27%
44. Knee Osteoarthritis 58%
45. Knee Surgery 27%
46. Lateral Collateral Ligament 20%
47. Leiomyosarcoma 27%
48. Leukocyte 27%
49. Local Anesthetic 27%
50. Magnetic Resonance Imaging 13%
51. Medical Device 27%
52. Medical History 36%
53. Medicine 15%
54. Micromorphology 27%
55. Neoplasm 25%
56. Neurofibromatosis Type I 27%
57. Oncology 33%
58. Operation on Joint 30%
59. Orthopedic Surgeon 54%
60. Orthopedics 70%
61. Orthotics 27%
62. Osseointegration 18%
63. Ossification 27%
64. Osteoarthritis 100%
65. Pathologic Fracture 13%
66. Patient Safety 27%
67. Periprosthetic Joint Infection 27%
68. Pheochromocytoma 27%
69. Pigmented Villonodular Synovitis 27%
70. Predictive Factor 22%
71. Prosthesis 30%
72. Prosthesis Loosening 49%
73. Proximal Femur 36%
74. Proximal Fibula 27%
75. Radiation Therapy 20%
76. Recurrence Risk 18%
77. Recurrent Disease 25%
78. Restylane 27%
79. Retrospective Study 66%
80. Revision Hip Arthroplasty 27%
81. Soft Tissue Sarcoma 56%
82. Sports Traumatology 27%
83. Stem Cell 30%
84. Stem Cell Therapy 21%
85. Stereotactic Radiosurgery 27%
86. Surgeon 36%
87. Surgery 46%
88. Synovectomy 18%
89. Systematic Review 54%
90. Tegner Activity Score 19%
91. Thalidomide 27%
92. Thrombocyte Rich Plasma 30%
93. Tibia 27%
94. Total Hip Arthroplasty 54%
95. Total Knee Arthroplasty 87%
96. Translational Medicine 27%
97. Unicompartmental Knee Arthroplasty 27%
98. Weight Bearing 27%
99. Well Differentiated Liposarcoma 27%
100. Western Ontario and McMaster Universities Osteoarthritis Index 36%